Daily Dose 2026
Documentation of Review and Resolution of Faculty Conflict of Interest
All questions used in the Daily Dose 2026 exam were written by the 2023, 2024, and 2025 Self-Assessment Examination Committees.
2023 Self-Assessment Examination Committee
Planners:
Committee Chair:
^Lawrence E. Weiss, MD
Committee Vice Chairs:
*Raymond K. Wurapa, MD
^Ethan W. Blackburn, MD
Reviewer:
^Lawrence E. Weiss, MD
Faculty:
^Reena Anjalie Bhatt, MD
*David J. Bozentka, MD
*Charles Cassidy, MD
*Kyle J. Chepla, MD
^Charles Andrew Daly, MD
*Paige M. Fox, MD, PhD
*Gregory G. Gallant, MD, MBA
^Joshua A. Gillis, MD
^Steven C. Haase, MD
^Scott L. Hansen, MD
^Michael W. Kessler, MD, MPH
*Steven M. Koehler, MD, FAAOS
^Lisa M. Kruse, MD
^Thomas P. Lehman, MD
^Ines C. Lin, MD
^Bilal Mahmood, MD
^Kristofer S. Matullo, MD
*Eitan Melamed, MD
^Omar Farooq Nazir, MD
^Jerome W. Oakey, MD
^Gavin D. O'Mahony, MD
^Allan E. Peljovich, MD, MPH
^Craig S. Phillips, MD
^Tyler Steven Pidgeon, MD
*Nicholas Pulos, MD
*Marc J. Richard, MD
^Luke P. Robinson, MD
^John V. Shufflebarger, MD
^Martin C. Skie, MD
^Amy L. Speeckaert, MD
*Ramesh C. Srinivasan, MD
*Adam B. Strohl, MD
*Simon G. Talbot, MD
*Carolyn J. Vaughn, MD
^Jennifer F. Waljee, MD, MPH
^Matthew Wilson, MD
^No relevant financial relationships to disclose.
The authors preceded by an ^ have indicated that they have no relevant financial relationships to disclose: salary received, royalty fees received, receipt of intellectual property rights/patent holder, consulting fees received, speakers bureau, fees for nonCME services received directly from a commercial interest or its agent, contracted research, ownership Interest (stocks, stock options, or other ownership interest excluding diversified mutual funds), or other financial relationships.
*Disclosures:
Raymond K. Wurapa, MD – Receipt of intellectual property rights for US Patents #d674,482, #d923,181, #us 11,166,750b1, #us10,973,550b2, #d913,597; Royalties from Medline, Uxton Biomedical, Innomed, Brownmed; Ownership interest in Tru-Colour Bandages LLC, Pricard Medical, OXOS; Speakers bureau for Field Orthopaedics
David J. Bozentka, MD – Contracted research for Axogen
Charles Cassidy, MD – Consulting fees from A.M. Surgical, Inc.
Kyle J. Chepla, MD – Consulting fees from Polynovo, Checkpoint Surgical
Paige M. Fox, MD, PhD - Ownership interest in Tyrb Health
Gregory G. Gallant, MD, MBA – Royalties from Elsevier
Steven M. Koehler, MD – Consulting fees from Trimed, Integra, TISSIUM; Speakers bureau for Integra; Ownership interest in Reactiv
Eitan Melamed, MD - Consulting fees from Rafael Holdings, Newclip Techniques
Nicholas Pulos, MD - Consulting fees from Klisbio; Honorarium from Trimed
Marc J. Richard, MD –Royalties from Field Orthopedics, Acumed, Elsevier, Resolve Surgical Technologies; Consulting fees from Acumed, Medartis, Bioventus; Speakers bureau for Acumed, Exsomed, Depuy Synthes, Medartis; Ownership interest in Restor3d
Ramesh C. Srinivasan, MD – Consulting fees from and speakers bureau for Axogen; consulting fees from Hinge Health; consulting fees from Turner Imaging Systems
Adam B. Strohl, MD – Consulting fees from A.M. Surgical, Inc., Axogen; Speakers bureau for Axogen
Simon G. Talbot, MD – Receipt of intellectual property rights for “Patent for sputter application of RFID devices”; Contracted research for the U.S. Department of Defense, the U.S. Health Resources & Services Administration; Consulting fees from TISSIUM, Six Theraputics Inc.
Carolyn J. Vaughn, MD - Spouse employed at Axogen
Staff:
Olivia Williams
Elaine Stewart
Disclosures: No relevant financial relations
2024 Self-Assessment Examination Committee
Planners:
Committee Chair:
^Lawrence E. Weiss, MD
Committee Vice Chairs:
*Raymond K. Wurapa, MD
*Ethan W. Blackburn, MD
Reviewer:
^Lawrence E. Weiss, MD
Faculty:
^Reena Anjalie Bhatt, MD
^David J. Bozentka, MD
*Charles Cassidy, MD
*Kyle J. Chepla, MD
^Charles Andrew Daly, MD
^Victor Fehrenbacher, MD
^Joshua A. Gillis, MD
^Steven C. Haase, MD
^Scott L. Hansen, MD
*Igor Immerman, MD
^Michael W. Kessler, MD, MPH
^Lisa M. Kruse, MD
^Peter R. Letourneau, MD
^Joseph Paul Letzelter, III, MD
^Ines C. Lin, MD
^Bilal Mahmood, MD
^Kristofer S. Matullo, MD
^Eitan Melamed, MD
^Jerome W. Oakey, MD
^Michael Jason Palmer, MD
^Allan E. Peljovich, MD, MPH
*Tyler Steven Pidgeon, MD
*Benjamin Forest Plucknette, DO, PT, DPT
*Nicholas Pulos, MD
*Marc J. Richard, MD
^Luke P. Robinson, MD
^John V. Shufflebarger, MD
^Martin C. Skie, MD
*Amy L. Speeckaert, MD
*Ramesh C. Srinivasan, MD
*Adam B. Strohl, MD
*Simon G. Talbot, MD
^Jignesh Unadkat, MD
^Carolyn J. Vaughn, MD
^Jennifer F. Waljee, MD, MPH
^Eric Daniel Wang, MD
^Matthew Wilson, MD
^No relevant financial relationships to disclose.
The authors preceded by an ^ have indicated that they have no relevant financial relationships to disclose: salary received, royalty fees received, receipt of intellectual property rights/patent holder, consulting fees received, speakers bureau, fees for nonCME services received directly from a commercial interest or its agent, contracted research, ownership Interest (stocks, stock options, or other ownership interest excluding diversified mutual funds), or other financial relationships.
*Disclosures:
Raymond K. Wurapa, MD – Ownership interest in Tru-Colour Products; consultant for Field Orthopaedics; royalties or patent beneficiary from Innomed, Medline
Ethan W. Blackburn, MD – Consultant for Arthrex
Charles Cassidy, MD – Speaker for A.M. Surgical, Inc.
Kyle J. Chepla, MD – Consulting fees from Polynovo, Checkpoint Surgical
Igor Immerman, MD – Advisor for BioInteractive Technologies; individual stocks/stock options in BioInteractive Technologies
Tyler Steven Pidgeon, MD – Consultant for Qpix, Restor3D, Tissium, Subchondral Solutions; researcher for Acumed, Medartis
Benjamin Forest Plucknette, DO, PT, DPT – Speaker for Skeletal Dynamics
Nicholas Pulos, MD – Speaker for Trimed
Marc J. Richard, MD – Royalties or patent beneficiary from Elsevier, Field Orthopaedics, Resolve Surgical Technologies, Restor3D, Acumed; speaker for Medartis
Amy L. Speeckaert, MD – Consultant for Johnson & Johnson
Ramesh C. Srinivasan – Consultant for Hinge Health, Turner Imaging Systems; consultant, researcher, and speaker for Acumed
Adam B. Strohl, MD – Consultant and speaker for Axogen, A.M. Surgical, Inc.
Simon G. Talbot, MD – Consultant for Neuraptive, Six Therapeutics, Tissium
Staff:
Olivia Williams
Elaine Stewart
Disclosures: No relevant financial relations
2025 Self-Assessment Examination Committee
Planners:
Committee Chair:
^Lawrence E. Weiss, MD
Committee Vice Chairs:
*Raymond K. Wurapa, MD
*Ethan W. Blackburn, MD
Reviewer:
^Lawrence E. Weiss, MD
Faculty:
^Reena Anjalie Bhatt, MD
^David J. Bozentka, MD
^Roy J. Caputo, MD
*Charles Cassidy, MD
*Kyle J. Chepla, MD
^Gregory K. Faucher, MD
^Victor Fehrenbacher, MD
^Paul A. Ghareeb, MD
^Steven C. Haase, MD
^Scott L. Hansen, MD
*Igor Immerman, MD
*Michael W. Kessler, MD, MPH
^Amy Kite, MD
^Lisa M. Kruse, MD
^Peter R. Letourneau, MD
^Joseph Paul Letzelter, III, MD
^Ines C. Lin, MD
^Bilal Mahmood, MD
^Kristofer S. Matullo, MD
*Eitan Melamed, MD
^Jerome W. Oakey, MD
*Michael Jason Palmer, MD
^Allan E. Peljovich, MD, MPH
*Tyler Steven Pidgeon, MD
*Benjamin Forest Plucknette, DO, PT, DPT
*Nicholas Pulos, MD
*Gregory H. Rafijah, MD
*Marc J. Richard, MD
*Luke P. Robinson, MD
*Ryan W. Schmucker, MD
^John V. Shufflebarger, MD
^Martin C. Skie, MD
*Amy L. Speeckaert, MD
*Ramesh C. Srinivasan, MD
*Adam B. Strohl, MD
*Simon G. Talbot, MD
^Jignesh Unadkat, MD
^Carolyn J. Vaughn, MD
^Eric Daniel Wang, MD
*David J. Wilson, MD, FAAOS
^No relevant financial relationships to disclose.
The authors preceded by an ^ have indicated that they have no relevant financial relationships to disclose: salary received, royalty fees received, receipt of intellectual property rights/patent holder, consulting fees received, speakers bureau, fees for nonCME services received directly from a commercial interest or its agent, contracted research, ownership Interest (stocks, stock options, or other ownership interest excluding diversified mutual funds), or other financial relationships.
*Disclosures:
Raymond K. Wurapa, MD – Ownership interest in Tru-Colour Products; consultant for Field Orthopaedics; royalties or patent beneficiary from Innomed, Medline
Ethan W. Blackburn, MD – Consultant for Arthrex
Charles Cassidy, MD – Speaker for A.M. Surgical, Inc.
Kyle J. Chepla, MD – Consultant for Polynovo, Checkpoint Surgical
Igor Immerman, MD – Advisor for BioInteractive Technologies; individual stocks/stock options in BioInteractive Technologies
Michael W. Kessler, MD, MPH – Consultant for Medartis, New Clip
Eitan Melamed, MD – Consultant for Axogen; royalties or patent beneficiary from NewClip Technics
Michael J. Palmer, MD – Individual stock/privately held in Unify Medical
Tyler Steven Pidgeon, MD – Consultant for Qpix, Restor3D, Tissium, Subchondral Solutions, Integra; researcher for Acumed, Medartis
Benjamin Forest Plucknette, DO, PT, DPT – Speaker for Skeletal Dynamics
Nicholas Pulos, MD – Speaker for Trimmed
Gregory H. Rafijah, MD – Consultant; speaker for Medartis
Marc J. Richard, MD – Royalties or patent beneficiary from Elsevier, Field Orthopaedics, Resolve Surgical Technologies, Restor3D, Acumed; speaker for Medartis, Acumed
Luke P. Robinson, MD – Consultant for Medartis
Ryan W. Schmucker, MD – Speaker for Trimed
Amy L. Speeckaert, MD – Consultant for Johnson & Johnson
Ramesh C. Srinivasan – Consultant for Hinge Health, Turner Imaging Systems; consultant, researcher, and speaker for Acumed
Adam B. Strohl, MD – Consultant and speaker for Axogen, A.M. Surgical, Inc.; speaker for Alafair
Simon G. Talbot, MD – Consultant for Neuraptive, Six Therapeutics, Tissium
David J. Wilson, MD, FAAOS – Consultant for Acumed
Staff:
Olivia Williams
Elaine Stewart
Disclosures:
No relevant financial relations
The ASSH adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.